Caplin Point Laboratories Limited Share Price NSE India S.E.
Equities
CAPLIPOINT
INE475E01026
Pharmaceuticals
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,332 INR | -1.77% | -0.17% | -1.75% |
16/04 | Caplin Point Arm Gets US FDA Final Nod for Ofloxacin Ophthalmic Solution | MT |
28/03 | Caplin Point Unit Receives US FDA Nod for Eye Treatment Medication | MT |
Sales 2024 * | 16.92B 203M | Sales 2025 * | 19.11B 229M | Capitalization | 103B 1.23B |
---|---|---|---|---|---|
Net income 2024 * | 4.57B 54.77M | Net income 2025 * | 4.17B 49.99M | EV / Sales 2024 * | 6.09 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 5.39 x |
P/E ratio 2024 * |
22.7
x | P/E ratio 2025 * |
21
x | Employees | 1,642 |
Yield 2024 * |
0.23% | Yield 2025 * |
0.25% | Free-Float | 25.33% |
Latest transcript on Caplin Point Laboratories Limited
1 day | -1.19% | ||
1 week | +0.42% | ||
Current month | +1.90% | ||
1 month | -2.29% | ||
3 months | -7.46% | ||
6 months | +32.07% | ||
Current year | -1.17% |
Managers | Title | Age | Since |
---|---|---|---|
Sridhar Ganesan
CEO | Chief Executive Officer | 69 | 28/15/28 |
D. Muralidharan
DFI | Director of Finance/CFO | - | 19/16/19 |
Anto V.
ADM | Chief Administrative Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | - | |
Chief Operating Officer | - | 01/10/01 | |
Sridhar Ganesan
CEO | Chief Executive Officer | 69 | 28/15/28 |
Date | Price | Change | Volume |
---|---|---|---|
02/24/02 | 1,332 | -1.77% | 38 493 |
30/24/30 | 1,356 | +0.81% | 37,391 |
29/24/29 | 1,346 | -0.74% | 40,318 |
26/24/26 | 1,356 | -0.12% | 72,784 |
25/24/25 | 1,357 | +1.58% | 91,456 |
Delayed Quote NSE India S.E., May 02, 2024 at 12:06 pm IST
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+21.22% | 43.18B | |
+20.67% | 22.59B | |
+15.11% | 14.56B | |
+38.74% | 11.5B | |
-8.37% | 6.93B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.21% | 5.36B | |
-2.27% | 4.81B |
- Stock Market
- Equities
- CAPLIPOINT Stock
- CAPLIPOINT Stock